AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vogelzang, NJ
Aklilu, M
Stadler, WM
Dumas, MC
Mikulski, SM
Citation: Nj. Vogelzang et al., A phase II trial of weekly intravenous ranpirnase (Onconase (R)), a novel ribonuclease in patients with metastatic kidney cancer, INV NEW DR, 19(3), 2001, pp. 255-260
Authors:
Newton, DL
Hansen, HJ
Mikulski, SM
Goldenberg, DM
Rybak, SM
Citation: Dl. Newton et al., Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma, BLOOD, 97(2), 2001, pp. 528-535
Authors:
Halicka, HD
Murakami, T
Papageorgio, CN
Mittelman, A
Mikulski, SM
Shogen, K
Darzynkiewicz, Z
Citation: Hd. Halicka et al., Induction of differentiation of leukaemic (HL-60) or prostate cancer (LNCaP, JCA-1) cells potentiates apoptosis triggered by onconase, CELL PROLIF, 33(6), 2000, pp. 407-417
Authors:
Lee, I
Lee, YH
Mikulski, SM
Lee, J
Shogen, K
Citation: I. Lee et al., Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase, ANTICANC R, 20(2A), 2000, pp. 1037-1040
Authors:
Lee, I
Lee, YH
Mikulski, SM
Lee, J
Covone, K
Shogen, K
Citation: I. Lee et al., Tumoricidal effects of onconase on various tumors, J SURG ONC, 73(3), 2000, pp. 164-171
Authors:
Vasandani, VM
Castelli, JC
Hott, JS
Saxena, S
Mikulski, SM
Youle, RJ
Citation: Vm. Vasandani et al., Interferon enhances the activity of the anticancer ribonuclease, onconase, J INTERF CY, 19(5), 1999, pp. 447-454
Authors:
Smith, MR
Newton, DL
Mikulski, SM
Rybak, SM
Citation: Mr. Smith et al., Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases, EXP CELL RE, 247(1), 1999, pp. 220-232
Risultati:
1-7
|